Clinical Trials Directory

Trials / Completed

CompletedNCT02117674

Full Spectrum vs. Standard Forward-viewing Colonoscopy

Full Spectrum vs. Standard Forward-viewing Colonoscopy With and Without Right-colon Retroflexion: a Randomized, Bicentric Back-to-back Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
246 (actual)
Sponsor
Attikon Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate FUSE-colonoscopy in terms of feasibility and its possible additive contribution in the detection of important lesions, namely polyps and cancers, compared to the standard "forward-viewing" approach, with and without the addition of the right-colon retroflexion technique, in a series of patients undergoing back-to-back screening or surveillance colonoscopies in a randomized fashion.

Detailed description

We changed the anticipated number of subjects enrollment for study: NCT02117674 from 120 to 200 based on the following sample size estimation: Tandem colonoscopies studies results, show that novel endoscopic technologies detect about 20% more adenomas than those conventional colonoscopy does (missed adenomas). Since FUSE colonoscopy cannot be considered as a perfect examination, we hypothesize that conventional colonoscopy will detect one third of the missed adenomas that FUSE detects in a similar setting. Therefore a sample size of 120 adenomas achieves 80% power to detect an odds ratio of 3.0 using a two-sided McNemar test with a significance level of 0.05. The odds ratio is equivalent to a difference between two paired proportions of 14% which occurs when the proportion of detected missed adenomas during FUSE is 21% and the proportion of missed adenomas during conventional colonoscopy is 7%. During one year period before the study initiation, our colonoscopy performance quality data show that we detect a mean number of adenomas per patient equal of 0.7 in a population similar to the one recruited in our study. Therefore, 172 patients overall will be required to detect 120 adenomas. Given the uncertainty of our estimation and in order to cope with patients exclusions, withdrawals and unexpected incomplete colonoscopies, we decided to recruit 200 patients. A more extensive description regarding the investigators study is provided in the following fields.

Conditions

Interventions

TypeNameDescription
PROCEDUREstandard forward-viewing colonoscopyexamination of the colon with a conventional colonoscope
PROCEDUREfull-spectrum colonoscopyexamination of the colon with full-spectrum colonoscope
PROCEDUREright colon retroflexionexamination of the right colon with scope retroflexion (both with conventional and fuse scope)

Timeline

Start date
2014-04-01
Primary completion
2015-07-01
Completion
2015-08-01
First posted
2014-04-21
Last updated
2015-12-31

Locations

2 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT02117674. Inclusion in this directory is not an endorsement.